Physician profile
Michael C Morell
NPI 1225393176
$19,791.29
in general payments reported to CMS, 2019-2025
11 companies · $795 in 2025
The $795 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,238 · 2020: $10K · 2021: $17.86 · 2022: $984 · 2023: $189 · 2024: $4,267 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,192 · Education: $1,643 · Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,192.03 |
| Education | $1,642.90 |
| Food and Beverage | $1,415.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,788.08 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,800.95 | 2024-2025 | Ligasure, Signia, Sonicision |
| Medical Device Business Services, INC. | $1,313.03 | 2019-2024 | Harmonic, Echelon; Endopath |
| Davol INC. | $1,119.96 | 2019-2025 | Phasix Mesh |
| Covidien LP | $703.77 | 2019-2020 | |
| Ethicon US, LLC | $396.37 | 2019-2025 | Echelon Endopath, Echelon Flex, Enseal |
| C. R. Bard, INC. & Subsidiaries | $369.28 | 2019 | |
| Tela Bio, INC. | $145.48 | 2024 | Ovitex 2s |
| Stryker Corporation | $71.67 | 2022 | |
| Baxter Healthcare | $47.41 | 2019 | |
| Conmed Corporation | $35.29 | 2022-2024 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.